News
The researchers found no effect of cannabinoids on acute pain or cancer pain, and they seemingly increased the risks of minor adverse events. The researchers, therefore, concluded that the harmful ...
In 1986 the World Health Organization (WHO) published analgesic guidelines for the treatment of cancer pain based on a three-step ladder and practical recommendations. These guidelines serve as an ...
Thoracic epidural analgesia provides pain relief superior to that of intravenous lidocaine in the first 24 hours after abdominal surgery, researchers reported. Thoracic epidural analgesia (TEA) is ...
Antidepressants are widely administered to chronic pain patients, but there is large interindividual variability in their efficacy and adverse effect rates that may be attributed to genetic factors.
Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The Christian Science Church, and we’ve always been transparent about that. The Church publishes the ...
The combined company will also retain Channel’s existing NaV 1.7 development programs for various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. In December ...
On January 30th, in a landmark decision that could reshape the way acute pain is treated in the United States, the FDA approved suzetrigine (brand name, Journavx), a first-in-class non-opioid ...
This laboratory model could be used to help explain certain pain syndromes, and offer a new way to test potential analgesic drugs, a Stanford team reports in the journal Nature. "It's exciting ...
This laboratory model could be used to help explain certain pain syndromes, and offer a new way to test potential analgesic drugs, a Stanford team reports in the journal Nature. "It's exciting," says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results